Some treatments for multiple myeloma have been used for over two decades. With all of excitement around new treatments like immunotherapies, how do these two different worlds converge or collide? Learn from Dr. Muzaffar Qazilbash, MD of the MD Anderson Cancer Center about the utility of stem cell transplant in the age of immunotherapy and how these may be used alone or together for optimal outcomes.   Special thanks to our episode sponsor, Takeda Oncology